1218 related articles for article (PubMed ID: 29971354)
1. Association of Inadequately Controlled Disease and Disease Severity With Patient-Reported Disease Burden in Adults With Atopic Dermatitis.
Simpson EL; Guttman-Yassky E; Margolis DJ; Feldman SR; Qureshi A; Hata T; Mastey V; Wei W; Eckert L; Chao J; Arnold RJG; Yu T; Vekeman F; Suárez-Fariñas M; Gadkari A
JAMA Dermatol; 2018 Aug; 154(8):903-912. PubMed ID: 29971354
[TBL] [Abstract][Full Text] [Related]
2. The patient-reported disease burden in adults with atopic dermatitis: a cross-sectional study in Europe and Canada.
de Bruin-Weller M; Gadkari A; Auziere S; Simpson EL; Puig L; Barbarot S; Girolomoni G; Papp K; Pink AE; Saba G; Werfel T; Eckert L
J Eur Acad Dermatol Venereol; 2020 May; 34(5):1026-1036. PubMed ID: 31587373
[TBL] [Abstract][Full Text] [Related]
3. Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2.
Cork MJ; Eckert L; Simpson EL; Armstrong A; Barbarot S; Puig L; Girolomoni G; de Bruin-Weller M; Wollenberg A; Kataoka Y; Remitz A; Beissert S; Mastey V; Ardeleanu M; Chen Z; Gadkari A; Chao J
J Dermatolog Treat; 2020 Sep; 31(6):606-614. PubMed ID: 31179791
[No Abstract] [Full Text] [Related]
4. Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2).
Silverberg JI; Gooderham MJ; Paller AS; Deleuran M; Bunick CG; Gold LFS; Hijnen D; Calimlim BM; Lee WJ; Teixeira HD; Hu X; Zhang S; Yang Y; Grada A; Platt AM; Thaçi D
Am J Clin Dermatol; 2024 May; 25(3):485-496. PubMed ID: 38528257
[TBL] [Abstract][Full Text] [Related]
5. Patient burden and quality of life in atopic dermatitis in US adults: A population-based cross-sectional study.
Silverberg JI; Gelfand JM; Margolis DJ; Boguniewicz M; Fonacier L; Grayson MH; Simpson EL; Ong PY; Chiesa Fuxench ZC
Ann Allergy Asthma Immunol; 2018 Sep; 121(3):340-347. PubMed ID: 30025911
[TBL] [Abstract][Full Text] [Related]
6. Validation of five patient-reported outcomes for atopic dermatitis severity in adults.
Silverberg JI; Margolis DJ; Boguniewicz M; Fonacier L; Grayson MH; Ong PY; Fuxench ZC; Simpson EL
Br J Dermatol; 2020 Jan; 182(1):104-111. PubMed ID: 30972740
[TBL] [Abstract][Full Text] [Related]
7. Extent and consequences of inadequate disease control among adults with a history of moderate to severe atopic dermatitis.
Wei W; Anderson P; Gadkari A; Blackburn S; Moon R; Piercy J; Shinde S; Gomez J; Ghorayeb E
J Dermatol; 2018 Feb; 45(2):150-157. PubMed ID: 29131384
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Patient-Oriented Eczema Measure and Patient-Oriented Scoring Atopic Dermatitis vs Eczema Area and Severity Index and other measures of atopic dermatitis: A validation study.
Silverberg JI; Lei D; Yousaf M; Janmohamed SR; Vakharia PP; Chopra R; Chavda R; Gabriel S; Patel KR; Singam V; Kantor R; Hsu DY
Ann Allergy Asthma Immunol; 2020 Jul; 125(1):78-83. PubMed ID: 32199977
[TBL] [Abstract][Full Text] [Related]
9. Symptoms and diagnosis of anxiety and depression in atopic dermatitis in U.S. adults.
Silverberg JI; Gelfand JM; Margolis DJ; Boguniewicz M; Fonacier L; Grayson MH; Ong PY; Chiesa Fuxench ZC; Simpson EL
Br J Dermatol; 2019 Sep; 181(3):554-565. PubMed ID: 30838645
[TBL] [Abstract][Full Text] [Related]
10. Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2).
Simpson EL; Prajapati VH; Leshem YA; Chovatiya R; de Bruin-Weller MS; Ständer S; Pink AE; Calimlim BM; Lee WJ; Teixeira H; Ladizinski B; Hu X; Yang Y; Liu Y; Liu M; Grada A; Platt AM; Silverberg JI
Dermatol Ther (Heidelb); 2024 May; 14(5):1127-1144. PubMed ID: 38696027
[TBL] [Abstract][Full Text] [Related]
11. Patient burden of moderate to severe atopic dermatitis (AD): Insights from a phase 2b clinical trial of dupilumab in adults.
Simpson EL; Bieber T; Eckert L; Wu R; Ardeleanu M; Graham NM; Pirozzi G; Mastey V
J Am Acad Dermatol; 2016 Mar; 74(3):491-8. PubMed ID: 26777100
[TBL] [Abstract][Full Text] [Related]
12. Content and construct validity, predictors, and distribution of self-reported atopic dermatitis severity in US adults.
Silverberg JI; Chiesa Fuxench ZC; Gelfand JM; Margolis DJ; Boguniewicz M; Fonacier L; Grayson MH; Simpson EL; Ong PY
Ann Allergy Asthma Immunol; 2018 Dec; 121(6):729-734.e4. PubMed ID: 30092267
[TBL] [Abstract][Full Text] [Related]
13. Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD).
Simpson EL; Gadkari A; Worm M; Soong W; Blauvelt A; Eckert L; Wu R; Ardeleanu M; Graham NMH; Pirozzi G; Sutherland ER; Mastey V
J Am Acad Dermatol; 2016 Sep; 75(3):506-515. PubMed ID: 27268421
[TBL] [Abstract][Full Text] [Related]
14. A real-world study evaluating adeQUacy of Existing Systemic Treatments for patients with moderate-to-severe Atopic Dermatitis (QUEST-AD): Baseline treatment patterns and unmet needs assessment.
Wei W; Ghorayeb E; Andria M; Walker V; Schnitzer J; Kennedy M; Chen Z; Belland A; White J; Silverberg JI
Ann Allergy Asthma Immunol; 2019 Oct; 123(4):381-388.e2. PubMed ID: 31325566
[TBL] [Abstract][Full Text] [Related]
15. Severity strata for five patient-reported outcomes in adults with atopic dermatitis.
Vakharia PP; Chopra R; Sacotte R; Patel N; Immaneni S; White T; Kantor R; Hsu DY; Simpson EL; Silverberg JI
Br J Dermatol; 2018 Apr; 178(4):925-930. PubMed ID: 29048751
[TBL] [Abstract][Full Text] [Related]
16. Severity strata for POEM, PO-SCORAD, and DLQI in US adults with atopic dermatitis.
Silverberg JI; Gelfand JM; Margolis DJ; Fonacier L; Boguniewicz M; Schwartz LB; Simpson E; Grayson MH; Ong PY; Fuxench ZCC
Ann Allergy Asthma Immunol; 2018 Oct; 121(4):464-468.e3. PubMed ID: 30003968
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology and Burden of Sleep Disturbances in Atopic Dermatitis in US Adults.
Silverberg JI; Chiesa-Fuxench Z; Margolis D; Boguniewicz M; Fonacier L; Grayson M; Simpson E; Ong P
Dermatitis; 2022 Nov-Dec 01; 33(6S):S104-S113. PubMed ID: 33675326
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of Pruritus in Relation to Self-assessed Severity of Atopic Dermatitis.
Huet F; Faffa MS; Poizeau F; Merhand S; Misery L; Brenaut E
Acta Derm Venereol; 2019 Mar; 99(3):279-283. PubMed ID: 30264161
[TBL] [Abstract][Full Text] [Related]
19. Validation of four single-item patient-reported assessments of sleep in adult atopic dermatitis patients.
Lei D; Yousaf M; Janmohamed SR; Vakharia PP; Chopra R; Chavda R; Gabriel S; Sacotte R; Patel KR; Singam V; Immaneni S; Kantor R; Hsu DY; Silverberg JI
Ann Allergy Asthma Immunol; 2020 Mar; 124(3):261-266. PubMed ID: 31830585
[TBL] [Abstract][Full Text] [Related]
20. Severity strata for Eczema Area and Severity Index (EASI), modified EASI, Scoring Atopic Dermatitis (SCORAD), objective SCORAD, Atopic Dermatitis Severity Index and body surface area in adolescents and adults with atopic dermatitis.
Chopra R; Vakharia PP; Sacotte R; Patel N; Immaneni S; White T; Kantor R; Hsu DY; Silverberg JI
Br J Dermatol; 2017 Nov; 177(5):1316-1321. PubMed ID: 28485036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
